These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30843536)

  • 1. Which is the destiny of ulipristal acetate for uterine fibroids? A commentary on the Italian medicines agency (AIFA) pronouncements.
    Indraccolo U; Conzadori S; Greco P
    Recenti Prog Med; 2019 Feb; 110(2):98-99. PubMed ID: 30843536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver safety parameters of ulipristal acetate for the treatment of uterine fibroids: a comprehensive review of the clinical development program.
    Donnez J; Arriagada P; Marciniak M; Larrey D
    Expert Opin Drug Saf; 2018 Dec; 17(12):1225-1232. PubMed ID: 30460871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What does non-eligibility for myoma surgery mean in the context of sequential prescription of ulipristal acetate?
    Pourcelot AG; Capmas P; Laberge P; Fernandez H
    J Gynecol Obstet Hum Reprod; 2020 Apr; 49(4):101688. PubMed ID: 31972353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ulipristal acetate and liver-injuries: while Esmya is revoked, EllaOne is allowed in repeated self-administrations possibly exceeding UPA toxic-dosing with Esmya.
    Mozzanega B
    J Hepatol; 2021 Mar; 74(3):750-751. PubMed ID: 33271158
    [No Abstract]   [Full Text] [Related]  

  • 5. Predictive factor for volume reduction of uterine fibroids after short-term use of ulipristal acetate.
    Yun BS; Seong SJ; Jung YW; Kim ML; Bae HS; Kim MK; Shim SS
    Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():133-136. PubMed ID: 29602142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ulipristal acetate for uterine fibroids: 2 years of real world experience in a UK hospital.
    Woodhead N; Pounds R; Irani S; Pradhan P
    J Obstet Gynaecol; 2018 Aug; 38(6):813-817. PubMed ID: 29526144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroid management in premenopausal women.
    Donnez J; Courtoy GE; Dolmans MM
    Climacteric; 2019 Feb; 22(1):27-33. PubMed ID: 30601065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of symptomatic uterine fibroids after ulipristal acetate suspension and identification of high risk patients for surgery at 6-months of follow-up.
    Nicolás I; Martínez-Zamora MÁ; Gracia M; Carrion A; Feixas G; Bernal L; Quintas L; Rius M; Castelo-Branco C; Carmona F
    Gynecol Endocrinol; 2021 Sep; 37(9):831-835. PubMed ID: 34044726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis.
    Gatti M; Poluzzi E; De Ponti F; Raschi E
    Drug Saf; 2020 Dec; 43(12):1277-1285. PubMed ID: 32748236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic drug evaluation of ulipristal acetate for the treatment of uterine fibroids.
    Ferrero S; Vellone VG; Barra F
    Expert Opin Drug Metab Toxicol; 2018 Jan; 14(1):107-116. PubMed ID: 29250979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical Therapy for Fibroids: What Next for Ulipristal Acetate?
    Ekanem E; Talaulikar V
    Adv Ther; 2021 Jan; 38(1):137-148. PubMed ID: 33201387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug safety evaluation of ulipristal acetate in the treatment of uterine fibroids.
    Tafi E; Scala C; Leone Roberti Maggiore U; Bizzarri N; Candiani M; Venturini PL; Ferrero S
    Expert Opin Drug Saf; 2015 Jun; 14(6):965-77. PubMed ID: 25772793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Evaluation of Postmarketing Reports of Serious Idiosyncratic Liver Injury Associated with Ulipristal Acetate for the Treatment of Uterine Fibroids.
    Kang S; Brinker A; Jones SC; Dimick-Santos L; Avigan MI
    Drug Saf; 2020 Dec; 43(12):1267-1276. PubMed ID: 32647996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, toxicological and clinical aspects of ulipristal acetate: insights into the mechanisms implicated in the hepatic toxicity.
    Dinis-Oliveira RJ
    Drug Metab Rev; 2021 Aug; 53(3):375-383. PubMed ID: 33905271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suspension of ulipristal acetate for uterine fibroids during ongoing EMA's review of liver injury risk: Unfortunate timing during the Covid-19 pandemic!
    Rozenberg S; Revercez P; Fastrez M; Vandromme J; Bucella D
    Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():300-302. PubMed ID: 32650189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated-intermittent use of ulipristal acetate for the management of uterine fibroids: an Italian pharmacoeconomic evaluation.
    Maratea D
    Minerva Ginecol; 2016 Feb; 68(1):15-20. PubMed ID: 26990098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver function, tolerability and satisfaction during treatment with ulipristal acetate in women with fibroids: a single center experience.
    Del Forno S; Degli Esposti E; Salucci P; Leonardi D; Iodice R; Arena A; Raimondo D; Paradisi R; Seracchioli R
    Gynecol Endocrinol; 2020 May; 36(5):445-447. PubMed ID: 31646908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute liver failure requiring transplantation: A possible link to ulipristal acetate treatment?
    Dinis-Oliveira RJ; Vieira DN
    Basic Clin Pharmacol Toxicol; 2021 Sep; 129(3):278-282. PubMed ID: 34187080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ulipristal acetate versus placebo for fibroid treatment before surgery.
    Donnez J; Tatarchuk TF; Bouchard P; Puscasiu L; Zakharenko NF; Ivanova T; Ugocsai G; Mara M; Jilla MP; Bestel E; Terrill P; Osterloh I; Loumaye E;
    N Engl J Med; 2012 Feb; 366(5):409-20. PubMed ID: 22296075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ulipristal acetate versus leuprolide acetate for uterine fibroids.
    Donnez J; Tomaszewski J; Vázquez F; Bouchard P; Lemieszczuk B; Baró F; Nouri K; Selvaggi L; Sodowski K; Bestel E; Terrill P; Osterloh I; Loumaye E;
    N Engl J Med; 2012 Feb; 366(5):421-32. PubMed ID: 22296076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.